NRX Pharmaceuticals, Inc. (NRXP) Q3 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Nrx Pharmaceuticals, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.198 Good morning, ladies and gentlemen, and welcome to the NRX Pharmaceuticals Q3 00:00:05.198 -- 00:00:06.660 2025 00:00:06.660 -- 00:00:11.947 Earnings Conference Call. At this time, all lines are in listen-only mode. 00:00:11.947 -- 00:00:16.053 Following the presentation, we will conduct a question and answer session. 00:00:16.053 -- 00:00:20.740 If at any time during this call you require immediate assistance, please press star zero 00:00:20.740 -- 00:00:27.206 for the operator. This call is being recorded on Monday, November 17, 2025. 00:00:27.487 -- 00:00:31.653 I would now like to turn the conference over to Matthew Duffy, Chief Business Officer. 00:00:31.653 -- 00:00:34.097 Please go ahead. 00:00:34.097 -- 00:00:38.343 Thank you, Joelle, and welcome everyone. Before we proceed with the call, I would like 00:00:38.343 -- 00:00:41.928 to remind everyone that certain statements made during this call are forward-looking 00:00:41.928 -- 00:00:45.033 statements under U.S. federal security laws. 00:00:45.033 -- 00:00:49.539 These statements are subject to risks and uncertainties that could cause actual results 00:00:49.539 -- 00:00:54.335 to differ materially from historical experience or present expectations. 00:00:54.335 -- 00:00:58.841 Additional information concerning factors that could cause actual results to differ from 00:00:58.841 -- 00:01:05.167 statements made on this call is contained in our periodic reports filed with the SEC. 00:01:05.190 -- 00:01:09.336 The forward-looking statements made during this call speak only as of the date hereof, 00:01:09.336 -- 00:01:14.784 and the company undertakes no obligation to update or revise forward-looking statements. 00:01:14.784 -- 00:01:18.369 Information presented on this call is...